17:56:39 EDT Mon 18 Oct 2021
Enter Symbol
or Name

Login ID:
Else Nutrition Holdings Inc
Symbol BABY
Shares Issued 67,138,650
Close 2019-10-25 C$ 0.50
Recent Sedar Documents

Else has composition patents for 19 countries

2019-10-28 07:59 ET - News Release

Mr. Hamutal Yitzhak reports


Else Nutrition Holdings Inc. has provided the following update to shareholders.

Key highlights

  • Composition patent granted for Else's formulation in 19 countries, with 47 countries patent pending;
  • Mexico is the latest country to provide a notice of allowance prior to granting the patent (September, 2019);
  • New Zealand is the latest country to grant the patent (July, 2019) following the United States, Japan, Australia, Eurasia, Ukraine, South Africa and Israel.

Else Nutrition holds a worldwide patent portfolio covering its 100-per-cent-plant-based toddler drink/formula which is scheduled to be launched in 2020, and for its 100-per-cent-plant-based infant formula, which is scheduled to be launched following FDA approval. Both products provide the infant and/or toddler with 100-per-cent-plant-based, whole balanced nutrition, without GMOs, antibiotics, hormones and gluten. The products provide nutrition suitable for infant and toddler dietary needs as required under the strict WHO guidelines. Else Nutrition's proprietary formula is all-natural, combining almond and buckwheat, and mimics the nutritional composition values of breast milk.

The patent, valid through 2034, protects a broad range of compositions comprising almonds in combination with one or more plant-based, non-dairy component for use in the nutrition of an infant and/or toddler. The granted patent claims also cover the use of the composition to supplement the nutrition of other age groups.

The patent was filed in various jurisdictions of interest to Else, with granted status already achieved in 19 countries, including the U.S., Australia, New Zealand, Japan, South Africa, Ukraine, Eurasia countries and Israel. An additional 47 countries have patents pending. In certain countries where patents have already been granted, additional patent applications were filed to cover other target audience demographics and product categories (such as supplemental and functional foods).

"We spent over five years to develop and perfect our proprietary formulations. The granted patent claims grant us the exclusive rights to produce, use, market and commercialize this variety of formulas and nutritional products for infants, toddlers and kids. The additional patent applications will grant us exclusive rights to expand our protected portfolio to adults and the elderly. The greatest value of our unique formulations stems from the fact that they provide 100-per-cent-plant-based, all-natural, wholesome balanced nutrition/meal replacement, that contains all nutritional needs of a subject. Further, the formulations are technology agnostic -- applicable to and protective of any type of food technology, spanning a diverse range from clinical or functional nutrition, to dairy-based alternatives, baked goods, pastas and many others," said Hamutal Yitzhak, chief executive officer and co-founder of Else Nutrition. She added, "This robust patent portfolio brings significant value and protection to the company, as we continue to innovate our leading-edge clean label solutions for consumers."

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.